Vanguard Global Advisers’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$283K Sell
14,843
-3,104
-17% -$66.3K ﹤0.01% 2339
2026
Q2
$330K Buy
17,947
+5,072
+39% +$76.7K ﹤0.01% 2288
2026
Q1
$230K Buy
+12,875
New +$182K ﹤0.01% 2369

Other funds holding VOR

Vanguard Global Advisers's VOR Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Vor Biopharma (VOR) stake by 17% in Q3 2026, selling an estimated $66.3K and leaving 14,843 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

Vanguard Global Advisers first reported a position in VOR in Q1 2026 and has held it in 3 quarters since. The position peaked at $330K in Q2 2026. 156 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Vanguard Global Advisers held 14,843 shares of Vor Biopharma worth $283K as of Q3 2026.
  • Vanguard Global Advisers sold 3,104 Vor Biopharma shares in Q3 2026, an estimated $66.3K.
  • Vor Biopharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2339 holding.
  • Vanguard Global Advisers first reported a position in Vor Biopharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Vor Biopharma position peaked at $330K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.